Samira Kalayinia

515 total citations
46 papers, 323 citations indexed

About

Samira Kalayinia is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Samira Kalayinia has authored 46 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 22 papers in Cardiology and Cardiovascular Medicine and 11 papers in Genetics. Recurrent topics in Samira Kalayinia's work include Cardiomyopathy and Myosin Studies (15 papers), Congenital heart defects research (13 papers) and Cardiovascular Effects of Exercise (6 papers). Samira Kalayinia is often cited by papers focused on Cardiomyopathy and Myosin Studies (15 papers), Congenital heart defects research (13 papers) and Cardiovascular Effects of Exercise (6 papers). Samira Kalayinia collaborates with scholars based in Iran, Canada and Switzerland. Samira Kalayinia's co-authors include Majid Maleki, Mahshid Malakootian, C. P. Singh, Nejat Mahdieh, Mohammad Mahdavi, Hamidreza Goodarzynejad, Alireza Biglari, Hassan Rokni‐Zadeh, Ghasem Hajianfar and Amir Farjam Fazelifar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Gene.

In The Last Decade

Samira Kalayinia

43 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samira Kalayinia Iran 9 180 101 76 44 38 46 323
Daniel S. Weintraub United States 4 142 0.8× 99 1.0× 32 0.4× 57 1.3× 76 2.0× 4 307
Ashok Kumar Manickaraj Canada 11 153 0.8× 106 1.0× 31 0.4× 69 1.6× 53 1.4× 15 289
Ravi Kumar Chilukoti Germany 8 179 1.0× 81 0.8× 127 1.7× 14 0.3× 34 0.9× 8 314
Seth D. Fortmann United States 12 155 0.9× 58 0.6× 42 0.6× 16 0.4× 44 1.2× 28 390
Avshesh Mishra India 9 77 0.4× 85 0.8× 55 0.7× 22 0.5× 38 1.0× 15 228
Nathan S. Doyle Australia 6 163 0.9× 50 0.5× 59 0.8× 64 1.5× 75 2.0× 9 558
Adam J. Guenzel United States 10 240 1.3× 91 0.9× 19 0.3× 40 0.9× 19 0.5× 15 347
Shuangshuang Pu China 5 175 1.0× 31 0.3× 101 1.3× 29 0.7× 20 0.5× 8 278
Dominika Łacheta Poland 5 66 0.4× 33 0.3× 53 0.7× 26 0.6× 39 1.0× 8 279
H.-P. Schultheiss Germany 10 114 0.6× 246 2.4× 24 0.3× 77 1.8× 47 1.2× 15 389

Countries citing papers authored by Samira Kalayinia

Since Specialization
Citations

This map shows the geographic impact of Samira Kalayinia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samira Kalayinia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samira Kalayinia more than expected).

Fields of papers citing papers by Samira Kalayinia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samira Kalayinia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samira Kalayinia. The network helps show where Samira Kalayinia may publish in the future.

Co-authorship network of co-authors of Samira Kalayinia

This figure shows the co-authorship network connecting the top 25 collaborators of Samira Kalayinia. A scholar is included among the top collaborators of Samira Kalayinia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samira Kalayinia. Samira Kalayinia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jolfayi, Amir Ghaffari, et al.. (2025). Pharmacogenomics in cardiac therapy: Personalizing treatment for heart health. Biomedicine & Pharmacotherapy. 190. 118392–118392. 2 indexed citations
2.
Maleki, Majid, et al.. (2024). Copy number variations: The potential association genetic cause in severe cardiovascular diseases with unknown aetiology. Journal of Cellular and Molecular Medicine. 28(12). 1 indexed citations
3.
Jolfayi, Amir Ghaffari, et al.. (2024). Identification of a Novel Likely Pathogenic TPM1 Variant Linked to Hypertrophic Cardiomyopathy in a Family with Sudden Cardiac Death. ESC Heart Failure. 11(5). 3180–3190. 1 indexed citations
4.
Jolfayi, Amir Ghaffari, et al.. (2024). A novel pathogenic variant in the carnitine transporter gene, SLC22A5, in association with metabolic carnitine deficiency and cardiomyopathy features. BMC Cardiovascular Disorders. 24(1). 1–1. 4 indexed citations
5.
Sadeghipour, Parham, et al.. (2023). Whole-exome sequencing uncovers a novel EFEMP2 gene variant (c.C247T) associated with dominant nonsyndromic thoracic aortic aneurysm. Laboratory Medicine. 55(4). 447–453. 1 indexed citations
6.
Maleki, Majid, et al.. (2023). Genetic Variations in the Human Angiotensin-ConvertingEnzyme 2 and Susceptibility to Coronavirus Disease-19. Genetics Research. 2023. 1–18. 2 indexed citations
7.
Maleki, Majid, et al.. (2023). Role of non‐coding variants in cardiovascular disease. Journal of Cellular and Molecular Medicine. 27(12). 1621–1636. 9 indexed citations
8.
Fazelifar, Amir Farjam, et al.. (2023). Identification of a novel pathogenic variant in KCNH2 in an Iranian family with long QT syndrome 2 by whole‐exome sequencing. Journal of Arrhythmia. 39(3). 430–453. 1 indexed citations
9.
Hajianfar, Ghasem, Samira Kalayinia, Mahdi Hosseinzadeh, et al.. (2023). Prediction of Parkinson’s disease pathogenic variants using hybrid Machine learning systems and radiomic features. Physica Medica. 113. 102647–102647. 9 indexed citations
10.
11.
Maleki, Majid, et al.. (2022). A novel stop-gain pathogenic variant in FLT4 and a nonsynonymous pathogenic variant in PTPN11 associated with congenital heart defects. European journal of medical research. 27(1). 286–286. 4 indexed citations
12.
13.
Maleki, Majid, et al.. (2021). In silico analysis of GATA4 variants demonstrates main contribution to congenital heart disease. SHILAP Revista de lepidopterología. 13(4). 336–354. 3 indexed citations
14.
15.
Maleki, Majid, et al.. (2021). Chromosome 9 Inversion: Pathogenic or Benign?A Comprehensive Systematic Review of all Clinical Reports. Current Molecular Medicine. 22(5). 385–400. 8 indexed citations
16.
Kalayinia, Samira, et al.. (2020). MicroRNAs: roles in cardiovascular development and disease. Cardiovascular Pathology. 50. 107296–107296. 114 indexed citations
17.
Kalayinia, Samira, et al.. (2020). Regional Distribution of Congenital Heart Disease in Iran; A Study on 1000 Iranian Hospitalized Patients in Three Years. 14(4). 2 indexed citations
18.
Kalayinia, Samira, Majid Maleki, Mohammad Mahdavi, & Nejat Mahdieh. (2019). A novel de novo dominant mutation of NOTCH1 gene in an Iranian family with non‐syndromic congenital heart disease. Journal of Clinical Laboratory Analysis. 34(4). e23147–e23147. 11 indexed citations
19.
20.
Kalayinia, Samira, Alireza Biglari, Hassan Rokni‐Zadeh, et al.. (2018). The Nkx2-5 Gene Mutations Related to Congenital Heart Diseases in Iranian Patients Population. 12(3). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel S. Weintraub Breakdown of academic impact, for papers by Ashok Kumar Manickaraj Breakdown of academic impact, for papers by Ravi Kumar Chilukoti Breakdown of academic impact, for papers by Seth D. Fortmann Breakdown of academic impact, for papers by Avshesh Mishra Breakdown of academic impact, for papers by Nathan S. Doyle Breakdown of academic impact, for papers by Adam J. Guenzel Breakdown of academic impact, for papers by Shuangshuang Pu Breakdown of academic impact, for papers by Dominika Łacheta Breakdown of academic impact, for papers by H.-P. Schultheiss
Rankless by CCL
2026